Drug Information

Drug General Information
Drug ID
D0X8CH
Former ID
DNCL002859
Drug Name
GSK2330672
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 2 [532355]
Company
GlaxoSmithKline
Target and Pathway
Target(s) Ileal bile acid transfer Target Info Modulator [532355]
KEGG Pathway Bile secretion
Reactome Recycling of bile acids and salts
WikiPathways Bile acid and bile salt metabolism
References
Ref 532355Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes. J Med Chem. 2013 Jun 27;56(12):5094-114.
Ref 532355Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes. J Med Chem. 2013 Jun 27;56(12):5094-114.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.